• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Researchers Receive $23.8 Million Grant to Test an Innovative Model to Improve HIV Prevention and Care

Article

Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs.

Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs. The project will test a system that relies on mobile technologies, home testing and an integrated care system in order to prevent HIV infection and provide better care for those who already have the virus that causes AIDS.

The Milken Institute School of Public Health at the George Washington University (Milken Institute SPH), together with the Rodham Institute of the GW School of Medicine and Health Sciences (SMHS), collaborated with more than 20 community partners including outreach organizations, clinical care systems, hospitals, managed care organizations, technology firms, the DC Department of Health, and DC Health Care Finance in order to successfully compete for and win the three-year award. The project will develop a shared Information Technology (IT) system that will provide Medicaid participants in the District of Columbia with preventive and chronic care services that are integrated across a range of settings, says Freya Spielberg, MD, MPH, who is the principal investigator on the project, an associate professor of prevention and community health at Milken Institute SPH, and an associate professor at the GW SMHS.

Read the full story: http://bit.ly/1oanIDd

Source: Infection Control Today

Related Videos
Screenshot of Adam Colborn, JD during an interview
dr ian neeland
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Jared Baeten
Jared Baeten
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.